Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $62000.0.

  • Pulse Biosciences' Capital Expenditures rose 6315.79% to $62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $263000.0, marking a year-over-year increase of 12869.57%. This contributed to the annual value of $125000.0 for FY2024, which is 330.58% up from last year.
  • Latest data reveals that Pulse Biosciences reported Capital Expenditures of $62000.0 as of Q3 2025, which was up 6315.79% from $103000.0 recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Capital Expenditures ranged from a high of $279000.0 in Q1 2022 and a low of $5000.0 during Q1 2024
  • Its 5-year average for Capital Expenditures is $68105.3, with a median of $45000.0 in 2025.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 8717.95% in 2024, then surged by 80000.0% in 2025.
  • Over the past 5 years, Pulse Biosciences' Capital Expenditures (Quarter) stood at $134000.0 in 2021, then tumbled by 69.4% to $41000.0 in 2022, then rose by 4.88% to $43000.0 in 2023, then rose by 23.26% to $53000.0 in 2024, then increased by 16.98% to $62000.0 in 2025.
  • Its Capital Expenditures stands at $62000.0 for Q3 2025, versus $103000.0 for Q2 2025 and $45000.0 for Q1 2025.